TCRX · TScan Therapeutics, Inc. · Analyst Estimates
$0.19
-0.01 (-2.76%)
At close · Oct 28
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 12, 2026
Market Cap
$13.06M
Shares
67.78M
Volume · Oct 28
121.51K
Avg daily vol (3M)
746.59K
Analyst Estimates
Compare analyst forecasts for TScan Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-06 23:34 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.89
|
-0.78
|
-0.62
|
4
|
-0.78
|
-0.87
|
-0.84
|
-0.84
|
0
|
1
|
3
|
2
|
|
Revenue
USD
Publication date not stated |
2.03M
|
2.92M
|
5.00M
|
4
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.03
|
-0.57
|
-0.27
|
4
|
-0.57
|
-0.94
|
-0.89
|
-0.89
|
0
|
0
|
3
|
4
|
|
Revenue
USD
Publication date not stated |
0.00
|
1.25M
|
5.00M
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.23
|
-0.18
|
-0.08
|
4
|
-0.18
|
-0.22
|
-0.22
|
-0.22
|
1
|
2
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
0.00
|
471,500.00
|
1.30M
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.21
|
-0.15
|
-0.09
|
4
|
-0.15
|
-0.22
|
-0.21
|
-0.21
|
0
|
0
|
3
|
4
|
|
Revenue
USD
Publication date not stated |
0.00
|
425,000.00
|
1.70M
|
4
|
— | — | — | — | — | — | — | — |